A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular ...
1d
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
Pulmonary hypertension, despite advances in treatment, still has a poor prognosis, which is often associated with right heart failure, and for which pulmonary arterial hypertension (PAH) is a severe ...
Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
ET indicates endothelin; ETA, endothelin type A; IP, prostaglandin I2; NO, nitric oxide; PAH, pulmonary arterial hypertension; PDE-5, phosphodiesterase type 5; and sGC, soluble guanylate cyclase.
Renowned Indian heart surgeon Dr K M Cherian, who was instrumental in several pioneering cardiac surgeries in India including the first successful coronary artery bypass and heart transplant ...
Titled “Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension,” the study was published in The Journal of Nuclear Medicine. PAH is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback